Screener
Vera Therapeutics VERA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $114,351 | $354,725 |
| Marketable securities | 482,409 | 359,864 |
| Prepaid expenses and other assets, current | 19,042 | 14,294 |
| Total current assets | 615,802 | 728,883 |
| Other assets, noncurrent | 5,937 | 5,850 |
| Total assets | $621,739 | $734,733 |
Item 1. Financial Statements
FAQ
- What is Vera Therapeutics's short-term investments?
- Vera Therapeutics (VERA) reported short-term investments of $482.41M in Q1 2026.
- How has Vera Therapeutics's short-term investments changed year-over-year?
- Vera Therapeutics's short-term investments decreased by 9.8% year-over-year, from $534.74M to $482.41M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Vera Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude